# Cost-effectiveness of novel antiandrogens (AAs) for treatment of nonmetastatic castrate-resistant prostate cancer (nmCRPC).

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-of-novel-antiandrogens-aas-for-treatment-of-nonmetastatic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Irbaz Bin Riaz,Abdulaali R. Almutairi,Daenielle K. Lang,Noureen Asghar,Anum Riaz,Yuan Yao,Qurat Ul Ain Riaz Sipra,Alexander J. Ryu,Nimer S. Alkhatib,Mok Oh,Ivo Abraham,M. Hassan Murad,Manish Kohli |
| Citations | 7 |
| DOI | 10.1200/jco.2020.38.15_suppl.5583 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3030071916 |
| Type | conference-abstract |
| Year | 2020 |

## Paper authors

- [Noureen Asghar](https://scholariq.org/researchers/noureen-asghar/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Paper topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.